Invention Grant
- Patent Title: Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase
-
Application No.: US16638051Application Date: 2018-08-16
-
Publication No.: US11267824B2Publication Date: 2022-03-08
- Inventor: Christoph Boss , Daniel Bur , Sylvaine Cren , Thierry Kimmerlin , Carina Lotz-Jenne , Julien Pothier , Naomi Tidten-Luksch
- Applicant: IDORSIA PHARMACEUTICALS LTD
- Applicant Address: CH Allschwil
- Assignee: IDORSIA PHARMACEUTICALS LTD
- Current Assignee: IDORSIA PHARMACEUTICALS LTD
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Associates LLC
- Priority: WOPCT/EP2017/070861 20170817
- International Application: PCT/EP2018/072187 WO 20180816
- International Announcement: WO2019/034725 WO 20190221
- Main IPC: C07D513/04
- IPC: C07D513/04 ; A61P35/00 ; A61K45/06
Abstract:
The present invention relates to compounds of Formula (I) inhibiting indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO) enzymes. Further, their synthesis and their use as medicaments in inter alia cancer is disclosed.
Public/Granted literature
- US20200216467A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE Public/Granted day:2020-07-09
Information query
